TaiMed Biologics: Comprehensive CDMO Services from Bench to Market
Exhibitor: TAIMED BIOLOGICS INC.
Date: 2024-06-25
Booth No.: M104
TaiMed Biologics is proud to offer its cost-competitive, high-quality Contract Development and Manufacturing Organization (CDMO) services from the hub of high-tech island, Taiwan. From early-stage development to full-scale commercialization, TaiMed Biologics offers a complete suite of CDMO services to support the development and manufacturing of monoclonal antibodies (mAbs).
Our US-FDA inspected state-of-the-art cGMP facility in Zhubei handles the entire spectrum of biologics development, including technology transfer, process development, formulation development, GMP manufacturing, analytical development, and regulatory affairs. With a commitment to quality and innovation, TaiMed Biologics ensures that your biologics journey is smooth and successful from bench to market.
Our team of experienced professionals provides personalized support and expert guidance at every stage of the development process. Whether you are a startup looking to bring a new biologic to clinical study or an established company seeking to optimize your production processes, TaiMed Biologics is your ideal partner.
Join us at Booth #M104, to explore how our CDMO services can accelerate your biologics development and manufacturing needs. Our experts will be available to discuss potential collaborations and answer any questions you may have.
More Exhibitor's Press Release
- 2024BIO Asia Taiwan. Golden Biotech Seminar Registration GOLDEN BIOTECHNOLOGY CORP. / 2024-06-28
- CRISPR cGMP gRNA Manufacturing MEDCLUB SCIENTIFIC CO., LTD. / 2024-06-27
- High-Throughput NGS Assistant - Feyond-F100 Fluorescence Microplate Reader MEDCLUB SCIENTIFIC CO., LTD. / 2024-06-27
- CLUBIO Life science solutions help universities upgrade equipments MEDCLUB SCIENTIFIC CO., LTD. / 2024-06-27
- OEM by QIAGEN: Strategic Partnerships – A Partner that Extends Your Capabilities QIAGEN N.V. / 2024-06-26
- EDA providing the most advanced and innovative optoelectronic medical equipment. EDA MEDICAL DEVICES TECHNOLOGY INC. / 2024-06-25
- Comparison of Maglev Centrifugal Pump and Quaternary Diaphragm Pump Effects on mRNA encapsulated LNP LEVITRONIX GMBH TAIWAN BRANCH / 2024-06-24
- Marker X Decodes the Cancer Proteome Breaking the Limits of Early Cancer Screening Globally! MARKER EXPLORATION CORP. / 2024-06-21
- EffPha is the leading CRO for early phase oncology trials EFFICIENT PHARMA MANAGEMENT CORP. / 2024-06-20
- FUJIFILM Toyama Chemical and Synplogen Enter Strategic Business Alliance Agreement on CDMO Services FUJIFILM CORPORATION / 2024-06-18
- TriLink BioTechnologies® and FUJIFILM Toyama Chemical Sign Non-exclusive License FUJIFILM CORPORATION / 2024-06-18
- BioBunBan is committed to manufacturing top-quality bio-materials BIOBUNBAN CO., LTD. / 2024-06-17
- BioBunBan is committed to manufacturing top-quality bio-materials BIOBUNBAN CO., LTD. / 2024-06-17
- Aggregating Experience, Leading the New Trend in Medical Micro-Molding ANN TONG INDUSTRIAL CO.,LTD / 2024-06-17
- SCIWIN Laboratories Co., Ltd. / Organic Synthesis R&D and Contract Manufacturing Organization SCIWIN LABORATORIES CO., LTD. / 2024-06-15
- INORA Brand Strategy to Drive Revenue Growth INORA PHARMACEUTICAL MACHINERY CO., LTD. / 2024-06-14
- SCI's highest quality static control equipment-------your best choice!! CHAO-DEE SCIENCE CO., LTD. / 2024-06-14
- Fujifilm to Invest $1.2 bn to Expand its Large-Scale Cell Culture CDMO Business in North Carolina FUJIFILM CORPORATION / 2024-06-14
- Diener Plasma equipments and Parylene Coating from Germany are worthy of your confidence and trust. CHAO-DEE SCIENCE CO., LTD. / 2024-06-14
- CSB promotes automated exosome production technology, leading the new trend in regenerative medicine COLD SPRING BIOTECH CORP. / 2024-06-13
